Sensible Biotechnologies formed a partnership with Nvidia

Sensible Biotechnologies (Miroslav Gašpárek and Marián Kupčulák) formed a partnership with Nvidia to accelerate the development of its mRNA therapeutics. The goal of producing therapeutic mRNA in living cells is to develop new drugs for cancer and genetic diseases. The company has research centers in Oxford and Boston, and partnerships with the Slovak Academy of Sciences and STU. It has already raised €13m from investors.

(forbes.sk)